These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38470700)

  • 1. Characteristics and Motivational Factors of Whole Blood and Convalescent Plasma Donors during the SARS-CoV-2 Pandemic in Israel.
    Shinar E; Jaffe E; Orr Z; Zalcman BG; Offenbacher J; Quint M; Alpert EA; Weiss BZ; Berzon B
    Healthcare (Basel); 2024 Mar; 12(5):. PubMed ID: 38470700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 convalescent plasma donor characteristics, product disposition, and comparison with standard apheresis donors.
    Lasky B; Goodhue Meyer E; Steele WR; Crowder LA; Young PP
    Transfusion; 2021 May; 61(5):1471-1478. PubMed ID: 33458811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 convalescent plasma donors: Unique motivations in unique times?
    Crowder LA; Steele WR; Goodhue E; Lasky B; Young PP
    Transfusion; 2023 Apr; 63(4):703-710. PubMed ID: 36866426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographics of first-time donors returning for donation during the pandemic: COVID-19 convalescent plasma versus standard blood product donors.
    Van Buren NL; Rajbhandary S; Reynolds V; Gorlin JB; Stramer SL; Notari EP; Conti G; Katz L; Stubbs JR; van Buskirk CM; Kuttner K; Smith DL; Ngamsuntikul SG; Pandey S; Ward DC; Ziman A; Hiskey M; Townsend M; Sachais BS
    Transfusion; 2023 Mar; 63(3):552-563. PubMed ID: 36550639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood group O convalescent plasma donations have significantly lower levels of SARS-CoV-2 IgG antibodies compared to blood group A donations.
    Hayes C; Rubenstein W; Gibb D; Klapper E; Tanaka J; Pepkowitz S
    Transfusion; 2021 Aug; 61(8):2245-2249. PubMed ID: 34036595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.
    Cho JH; Rajbhandary S; van Buren NL; Fung MK; Al-Ghafry M; Fridey JL; Dy BA; Ziman A; Schreiber GB; Gammon RR; Reik R; Stubbs JR; van Buskirk CM; Kamel H; Townsend MJ; Zeller MP; Gottschall JL
    Transfusion; 2021 Sep; 61(9):2668-2676. PubMed ID: 34227689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening donors for COVID-19 convalescent plasma.
    Wang HE; Ostrosky-Zeichner L; Katz J; Wanger A; Bai Y; Sridhar S; Patel B
    Transfusion; 2021 Apr; 61(4):1047-1052. PubMed ID: 33368395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of a pilot program for COVID-19 convalescent plasma collection in Wuhan, China.
    Li L; Yang R; Wang J; Lv Q; Ren M; Zhao L; Chen H; Xu H; Xie S; Xie J; Lin H; Li W; Fang P; Gong L; Wang L; Wu Y; Liu Z
    Transfusion; 2020 Aug; 60(8):1773-1777. PubMed ID: 32491199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of 52 240 source plasma donors of convalescent COVID-19 plasma: Sex, ethnicity, and age association with initial antibody levels and rate of dissipation.
    Schmidt AE; Vogel P; Chastain CA; Barnes T; Roth NJ; Simon TL
    J Clin Apher; 2022 Oct; 37(5):449-459. PubMed ID: 35815776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of coronavirus disease 19 convalescent plasma donors and donations in the New York metropolitan area.
    Jain S; Garg K; Tran SM; Rask IL; Tarczon M; Nandi V; Kessler DA; Strauss D; Sachais BS; Yazdanbakhsh K; Rehmani S; Luchsinger L; Shi PA
    Transfusion; 2021 Aug; 61(8):2374-2383. PubMed ID: 33904609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 neutralizing capacity among blood donors without prior COVID-19 symptomatic history vs. blood donors with prior COVID-19 symptomatic history: A comparative study.
    Ravula U; Chunchu SR; Mooli S; Naik R; Sarangapati PRR
    Transfus Clin Biol; 2022 May; 29(2):107-111. PubMed ID: 35167958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualifying coronavirus disease 2019 convalescent plasma donors in Israel.
    Izak M; Gendelman V; Bransburg-Zabary S; Stoyanov E; Gat R; Cohen D; Chen J; Maor Y; Benov A; Lev B; Zimhony O; Shinar E
    Vox Sang; 2022 Feb; 117(2):185-192. PubMed ID: 34125976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal analysis of SARS-CoV-2 antibodies in 8000 U.S. first-time convalescent plasma donations.
    Karbiener M; Farcet MR; Ilk R; Schreiner J; Lenart J; Powers N; Stewart JM; Tallman H; Kreil TR
    Transfusion; 2021 Apr; 61(4):1141-1147. PubMed ID: 33615484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deterrents in recruitment of COVID-19 convalescent plasma donors: Experience from a hospital-based blood centre in India.
    Dhiman Y; Coshic P; Pandey HC; Khatiwada B; Singh J; Mehta V; Gupta S
    Transfus Med; 2021 Jun; 31(3):149-154. PubMed ID: 33749020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How we secured a COVID-19 convalescent plasma procurement scheme in Japan.
    Terada M; Kutsuna S; Togano T; Saito S; Kinoshita N; Shimanishi Y; Suzuki T; Miyazato Y; Inada M; Nakamoto T; Nomoto H; Ide S; Sato M; Maeda K; Matsunaga A; Satake M; Matsubayashi K; Tsuno H; Kojima M; Kuramistu M; Tezuka K; Ikebe E; Okuma K; Hamaguchi I; Shiratori K; Sato M; Kawakami Y; Inaba K; Igarashi S; Yamauchi R; Matsumura M; Ishimaru K; Zhang B; Kuge C; Ishihara M; Gouda M; Tanaka K; Ishizaka Y; Ohmagari N
    Transfusion; 2021 Jul; 61(7):1998-2007. PubMed ID: 34096059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motivators of and barriers to becoming a COVID-19 convalescent plasma donor: A survey study.
    Masser BM; Ferguson E; Thorpe R; Lawrence C; Davison TE; Hoad V; Gosbell IB
    Transfus Med; 2021 Jun; 31(3):176-185. PubMed ID: 33368777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motivation, blood donor satisfaction and intention to return during the COVID-19 pandemic.
    Weidmann C; Derstroff M; Klüter H; Oesterer M; Müller-Steinhardt M
    Vox Sang; 2022 Apr; 117(4):488-494. PubMed ID: 34725833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach to increasing inventory with the current panel: increasing donation frequency by asking for a different blood product.
    Bagot KL; Masser BM; White KM
    Transfusion; 2015 Jun; 55(6):1294-302. PubMed ID: 25652648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood Group Variations in COVID-19 Convalescent Plasma and Regular Blood Donors: A Comparative Analysis in the Serbian Population.
    Grujić J; Budakov-Obradović Z; Klašnja J; Dinić R; Dolinaj V; Cabezas-Cruz A; Banović P
    Microorganisms; 2024 Apr; 12(5):. PubMed ID: 38792740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital-Based Donor Recruitment and Predonation Serologic Testing for COVID-19 Convalescent Plasma.
    Balcerek J; Trejo E; Levine K; Couey P; Kornberg ZV; Rogine C; Young C; Li PJ; Shy BR; Taylor JE; Bakhtary S; Friedlander T; Lynch KL; Bern C; Esensten JH
    Am J Clin Pathol; 2021 Mar; 155(4):515-521. PubMed ID: 33399201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.